Cboe and Citadel Securities-backed industry body contests CFTC green light for single-stock perpetual derivatives

The Capital Markets Alliance (CMA), backed by Cboe and Citadel Securities, sued the CFTC over its approval of single-stock perpetual derivatives. The CMA argues these products should fall under SEC jurisdiction and that the CFTC violated the Administrative Procedure Act. The CMA seeks to vacate the approvals, but a judge denied an emergency restraining order, indicating the CMA may succeed in its claim. The CFTC and CMA are set to respond by November 6 and 10, respectively.

Original reporting
Published Nov 5, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 12:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cboe and Citadel Securities-backed industry body contests CFTC green light for single-stock perpetual derivatives — source image
Decision brief

The 30-second read

$CBOEBearishMed
01

Why it matters

The legal challenge introduces regulatory risk for a nascent product class, potentially delaying its rollout and affecting market participants who anticipate trading these instruments.

02

Market read

Regulatory uncertainty around single‑stock perpetual derivatives could influence equity and ETF pricing, as well as the broader derivatives market.

03

What to watch

The lawsuit may prompt the CFTC to refine its rulemaking, leading to clearer guidelines that could benefit long‑term market structure.

Relevance 7/10Novelty 8/10Timing: immediate, as the suit was filed this week

Background

The Capital Markets Alliance, comprising Cboe, Citadel Securities and Healthy Markets Association, argues that single‑stock perpetual derivatives should be regulated by the SEC as security‑based swaps.

Company-level read

Ticker impact

$CBOEBearishHigh confidence
Context

Cboe is a founding member of the Capital Markets Alliance that filed a lawsuit challenging the CFTC's approval of single‑stock perpetual derivatives.

Expected impact

likely downward pressure on equities and related ETFs as investors assess regulatory risk.

Evidence & confidence

The lawsuit is a fresh regulatory action that may halt or reshape a new product class, creating uncertainty for market participants.

Market effects

Potential slowdown in the growth of single‑stock perpetual derivatives could affect the broader derivatives and ETF sectors.

U.S. equity markets may see heightened volatility amid regulatory uncertainty.

Regulatory outcome could set a precedent for other jurisdictions considering similar products.

Counterpoint

If the court ultimately permits the products, the market could rally on the back of new trading opportunities.

Key entities

  • Capital Markets Alliance

    Industry body filing the lawsuit.

  • CFTC

    Approved the perpetual derivatives now being challenged.

Related articles

$CBOEMed

Cboe and Citadel Securities Are Suing to Overturn the CFTC’s Approval of Stock Perpetual Futures. Could That Slow Hyperliquid?

Cboe Global Markets (CBOE) and Citadel Securities sued to overturn the CFTC's approval of stock perpetual futures, which Hyperliquid (HYPE) lists outside the U.S. The lawsuit aims to classify these contracts as security-based swaps and halt trading. HYPE's token is trading at $86, down 1.3% in 24 hours but up 7.4% in a week. The lawsuit could impact U.S. exchanges like Coinbase (COIN) and Bitnomial, while Hyperliquid's offshore operations may face fewer competitors in the short term.

$CBOELow

Analysis: Cboe, Citadel Securities backed group sues CFTC over stock perpetuals

The Capital Markets Alliance (CMA), backed by Cboe and Citadel Securities, sued the CFTC to halt perpetual futures trading on individual US stocks, arguing they should be classified as security-based swaps. The CFTC approved the contracts, but the CMA claims they should require SEC registration for retail sales. The lawsuit also questions the CFTC's approval process, which automatically approved the products after 45 days without objection.

$CBOEMed

CFTC Perpetual Futures on Stocks Hit by Cboe-Backed Lawsuit

CFTC approved perpetual futures tied to individual stocks for trading on US exchanges. Chairman Michael Selig stated the contracts are approved under Commission Regulation 40.3. The Capital Markets Alliance, including Cboe, Citadel Securities, and others, filed a lawsuit challenging the approval, arguing the contracts fall under SEC jurisdiction and alleging procedural violations. Cboe's CEO Craig Donohue stated the approvals threaten investor protection and market integrity.

$CBOEMed

Cboe and Citadel Sue to Stop US Stock Perps Hours After the CFTC Approved Them: Why Hyperliquid’s $5 Billion-a-Day Market Has the Most at Stake

Cboe and Citadel Securities sued the CFTC to block stock perpetual futures, hours after the regulator approved them. The lawsuit aims to prevent US exchanges from offering these products, which are popular on Hyperliquid's platform. Hyperliquid's HYPE token saw volatility but remains up 2.8% in 24 hours. The outcome could impact Hyperliquid's US market expansion and competitors like Coinbase and Kalshi.

$CBOEMed

Cboe Joins CMA Lawsuit Seeking to Overturn CFTC Stock Perpetual Approval

Cboe joined the Capital Markets Alliance (CMA) in suing to overturn the CFTC's approval of single-stock perpetual contracts. The case seeks to classify these derivatives as security-based swaps and block the approval. The CFTC allowed trading to begin on Nov. 3, while Cboe's CEO argues they should be regulated under U.S. securities laws. The case involves Coinbase, Kalshi, and Bitnomial.